Lv1
76 积分 2025-05-16 加入
Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance
12天前
已完结
NIR-II aggregation-induced emission nanoparticles camouflaged with preactivated macrophage membranes for phototheranostics of pulmonary tuberculosis
1个月前
已完结
Bacterial Outer Membrane‐Coated Mesoporous Silica Nanoparticles for Targeted Delivery of Antibiotic Rifampicin against Gram‐Negative Bacterial Infection In Vivo
1个月前
已完结
Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles
1个月前
已完结
Encapsulation and stability of clofazimine liposomes
2个月前
已完结
Immune evasion and provocation by Mycobacterium tuberculosis
2个月前
已完结
Multidrug-resistant tuberculosis
2个月前
已完结
Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease
2个月前
已完结
Design, development, and characterisation of clofazimine-loaded mannosylated nanostructured lipid carriers: 33-Box-Behnken design approach
3个月前
已完结
Nanostructured lipid carrier-mediated lung targeted drug delivery system to enhance the safety and bioavailability of clofazimine
3个月前
已完结
皖公网安备34019202002308
